Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer cachexia.

Kenneth C H Fearon1, Alastair G W Moses

  • 1Department of Clinical and Surgical Sciences (Surgery), Royal Infirmary of Edinburgh, Edinburgh, UK. k.earon@ed.ac.uk

International Journal of Cardiology
|August 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle.

PloS one·2024
Same author

Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers.

Biomedical reports·2019
Same author

Urinary diagnostic proteomic markers for dynapenia in cancer patients.

Biomedical reports·2018
Same author

Proteomic identification of potential markers of myosteatosis in human urine.

Biomedical reports·2018
Same author

Cancer-associated cachexia.

Nature reviews. Disease primers·2018
Same author

Alterations in the in vitro and in vivo regulation of muscle regeneration in healthy ageing and the influence of sarcopenia.

Journal of cachexia, sarcopenia and muscle·2017
Same journal

Fully quantitative CMR rest perfusion reveals myocardial perfusion abnormality in Kawasaki disease: Association with left ventricular Remodeling.

International journal of cardiology·2026
Same journal

Predicted adherence and ischaemic stroke risk in atrial fibrillation patients initiating oral anticoagulation: A cohort study of the medication adherence score.

International journal of cardiology·2026
Same journal

Severe tricuspid regurgitation is a congestion-driven cardiorenal disease: A longitudinal study defining a right heart failure phenotype.

International journal of cardiology·2026
Same journal

Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.

International journal of cardiology·2026
Same journal

Effectiveness of a new diagnostic algorithm for the diagnosis of unexplained syncope in patients with hypertrophic cardiomyopathy.

International journal of cardiology·2026
Same journal

The predictive role of the FIB-4 index in identifying arrhythmic risk among patients with nonischemic dilated cardiomyopathy.

International journal of cardiology·2026
See all related articles

Cancer cachexia, a syndrome of reduced food intake and metabolic changes, involves multiple pathways. Combination therapies targeting nutrition and metabolism may improve cancer patients' quality of life.

Area of Science:

  • Oncology
  • Metabolic Medicine
  • Nutrition Science

Background:

  • Cancer cachexia is a complex syndrome characterized by reduced food intake and metabolic abnormalities.
  • It involves pro-inflammatory cytokines, neuroendocrine hormones, and tumor-specific factors.
  • Current therapeutic approaches are often insufficient to address the multifactorial nature of the syndrome.

Purpose of the Study:

  • To explore the underlying mechanisms of cancer cachexia.
  • To evaluate the potential of multi-model therapeutic approaches.
  • To investigate the benefits of combining nutritional support with metabolic and inflammation modulation.

Main Methods:

  • Review of existing literature on cancer cachexia.
  • Analysis of mediator pathways involved in the syndrome.

Related Experiment Videos

  • Conceptualization of integrated treatment strategies.

    • Main Results:

    • Cancer cachexia results from a combination of reduced food intake and metabolic derangements, including hypermetabolism.
    • Multiple biological pathways contribute to the development of cachexia.
    • Combined therapeutic interventions show promise for improving patient outcomes.

    Conclusions:

    • Effective management of cancer cachexia necessitates a multi-model approach.
    • Integrating nutritional support with metabolic and inflammation modulation is a promising strategy.
    • This integrated approach has the potential to enhance functional capacity and quality of life for cancer patients.